Steven M. Paul, M.D.
Steven M. Paul, M.D.
Director of the Helen and Robert Appel Alzheimer’s Disease Research Institute
Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases
Professor of Neuroscience, Psychiatry and Pharmacology
Dr. Paul’s research efforts have established an important role for specific neurotransmitter receptors in mediating the central actions of various neuroactive drugs and particularly the delineation of the role of receptors for the inhibitory neurotransmitter GABA. His work has also helped shed light on genetic factors that dramatically increase risk for Alzheimer's and actually cause the brain abnormalities (plaques and tangles) that lead to the loss of neurons and the symptoms of the disease. While working at Eli Lilly and Company as Executive Vice President of Science and Technology and President of the Lilly Research Laboratories (LRL), his research team discovered a novel potential new treatment for Alzheimer's disease (an antibody called solanezumab) beleved to clear amyloid plaques from the brain. It is in the final phase of clinical testing.
Prior to assuming his position at Lilly, he served as Scientific Director of the National Institute of Mental Health (NIMH/NIH) in Bethesda, Maryland.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.